Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

OBJECTIVE: To investigate the efficacy of switching to a second biological drug in rheumatoid arthritis (RA) patients. METHODS: Since 2000, Danish RA patients (n  =  1021) receiving biological therapy have been registered in the nationwide DANBIO database. The first and second treatment series of pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hjardem, Elisabeth, Østergaard, Mikkel, Pødenphant, Jan, Tarp, Ulrik, Andersen, Lis Smedegaard, Bing, Jette, Peen, Elisabeth, Lindegaard, Hanne Merete, Ringsdal, Vibeke Stevenius, Rødgaard, Anne, Skøt, Jens, Hansen, Annette, Mogensen, Hans Henrik, Unkerskov, Janne, Hetland, Merete Lund
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955158/
https://ncbi.nlm.nih.gov/pubmed/17389656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.054742
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados